Sec. 808. Public docket on proposed modifications to approved strategies
232 words·~1 min read·
/bill/117/hr/7667/ih/section-808·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Not later than 90 days after the date of the enactment of this Act, the Secretary of Health and Human Services shall open a public docket for the submission of public comments regarding factors related to patient access to a drug that is subject to a risk evaluation and mitigation strategy and the administration or prescribing of such drug by health care providers that should be taken into consideration when a proposed modification to such strategy is reviewed under section 505–1(h) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 255–1(h) ).
The Secretary may close such public docket not earlier than 90 days after such docket is opened. Not later than December 31, 2026, the Comptroller General of the United States shall submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate a report on— the number of proposed modifications to an approved risk evaluation and mitigation strategy the Secretary has granted under section 505–1(h) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 255–1(h) ); any issues affecting patient access to the drug that is subject to the strategy or considerations with respect to the administration or prescribing of such drug by health care providers that arose as a result of such modifications; and how such issues were resolved, as applicable.
Connections1 off-index
1 reference not yet in our index
- 21 USC 255–1(h)
Citation graph
cites case law
Sec. 808
Public docket on proposed modifications to approved strategies
Cite21 USC 255–1(h)
Cites 1Cited by 0 across 0 sources